RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Recordati Industria Chimica e Farmaceutica SpA Stock

Recordati Industria Chimica e Farmaceutica SpA Employees 2024

Recordati Industria Chimica e Farmaceutica SpA Employees

4,323

Ticker

REC.MI

ISIN

IT0003828271

WKN

A0EABR

In 2024, Recordati Industria Chimica e Farmaceutica SpA employed 4,323 people, a 0% change from the 4,323 number of employees in the previous year.

Recordati Industria Chimica e Farmaceutica SpA Aktienanalyse

What does Recordati Industria Chimica e Farmaceutica SpA do?

Recordati Industria Chimica e Farmaceutica SpA is an Italian pharmaceutical company based in Milan. The company was founded in 1926 by Giovanni Recordati and now has branches in many countries worldwide. Recordati's business model is based on the development, production, and marketing of drugs for various therapeutic areas. The company focuses particularly on therapy areas such as cardiology, urology, gastroenterology, pneumology, and hematology. Recordati operates in four business areas: Innovative Medicines, OTC Medicines, Generics, and Licensed Products. In the area of innovative medicines, the company specializes in the development of new active substances for the treatment of rare diseases. In the OTC Medicines area, Recordati specializes in the manufacture and marketing of over-the-counter drugs used to treat mild to moderate complaints. The generics area includes the production and marketing of generic products with the aim of influencing price development in the market. In the Licensed Products area, Recordati collaborates with other companies and takes over the marketing of their products in certain regions. Some of Recordati's best-known products include Cariprazine (an antipsychotic), Urolith (a preventive treatment for kidney stones), Zanipress (a treatment for hypertension), and Fokusin (a treatment for benign prostatic hyperplasia). Recordati is also committed to improving access to life-saving medications worldwide. The company engages in collaborations with international organizations such as the Global Alliance for TB Drug Development and supports the WHO's "Target Product Profiles" initiative. In 2019, Recordati Industria Chimica e Farmaceutica SpA achieved sales of around 1.4 billion euros in over 90 countries. The company employs about 4,200 people worldwide, including approximately 500 researchers and developers. In terms of future direction, Recordati sees continued high potential for growth and expansion, particularly through targeted investments in research and development. The company relies on close cooperation with other partners within the industry and the exploration of new markets and therapeutic areas. Recordati Industria Chimica e Farmaceutica SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Recordati Industria Chimica e Farmaceutica SpA's Employee Base

Recordati Industria Chimica e Farmaceutica SpA's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Recordati Industria Chimica e Farmaceutica SpA's operational capacity and future potential.

Year-to-Year Comparison

Assessing Recordati Industria Chimica e Farmaceutica SpA's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Recordati Industria Chimica e Farmaceutica SpA's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Recordati Industria Chimica e Farmaceutica SpA’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Recordati Industria Chimica e Farmaceutica SpA stock

How many employees does Recordati Industria Chimica e Farmaceutica SpA have this year?

Recordati Industria Chimica e Farmaceutica SpA has 4,323 undefined employees this year.

How many employees did Recordati Industria Chimica e Farmaceutica SpA have compared to the previous year?

Compared to the previous year, Recordati Industria Chimica e Farmaceutica SpA had 0% more employees.

What impact did the number of employees have on the company Recordati Industria Chimica e Farmaceutica SpA?

The number of employees has a direct impact on the efficiency and productivity of Recordati Industria Chimica e Farmaceutica SpA. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Recordati Industria Chimica e Farmaceutica SpA?

The number of employees can also have an impact on investors of Recordati Industria Chimica e Farmaceutica SpA, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Recordati Industria Chimica e Farmaceutica SpA affect the company?

An increase in equity of Recordati Industria Chimica e Farmaceutica SpA can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Recordati Industria Chimica e Farmaceutica SpA's equity affect the company?

A reduction in equity of Recordati Industria Chimica e Farmaceutica SpA can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Recordati Industria Chimica e Farmaceutica SpA?

Some factors that can influence the equity of Recordati Industria Chimica e Farmaceutica SpA include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Recordati Industria Chimica e Farmaceutica SpA so important for investors?

The equity of Recordati Industria Chimica e Farmaceutica SpA is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Recordati Industria Chimica e Farmaceutica SpA influence the company?

The number of employees at Recordati Industria Chimica e Farmaceutica SpA can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Recordati Industria Chimica e Farmaceutica SpA evolved in recent years?

In recent years, the number of employees at Recordati Industria Chimica e Farmaceutica SpA has changed by 0.

How many employees does Recordati Industria Chimica e Farmaceutica SpA currently have?

Recordati Industria Chimica e Farmaceutica SpA currently has 4,323 undefined employees.

Why is the number of employees important for investors of Recordati Industria Chimica e Farmaceutica SpA?

The number of employees is important for investors of Recordati Industria Chimica e Farmaceutica SpA as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Recordati Industria Chimica e Farmaceutica SpA take to change the number of employees?

To change the number of employees, Recordati Industria Chimica e Farmaceutica SpA can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Recordati Industria Chimica e Farmaceutica SpA pay?

Over the past 12 months, Recordati Industria Chimica e Farmaceutica SpA paid a dividend of 1.17 EUR . This corresponds to a dividend yield of about 2.32 %. For the coming 12 months, Recordati Industria Chimica e Farmaceutica SpA is expected to pay a dividend of 1.25 EUR.

What is the dividend yield of Recordati Industria Chimica e Farmaceutica SpA?

The current dividend yield of Recordati Industria Chimica e Farmaceutica SpA is 2.32 %.

When does Recordati Industria Chimica e Farmaceutica SpA pay dividends?

Recordati Industria Chimica e Farmaceutica SpA pays a quarterly dividend. This is distributed in the months of June, December, June, December.

How secure is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

Recordati Industria Chimica e Farmaceutica SpA paid dividends every year for the past 0 years.

What is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

For the upcoming 12 months, dividends amounting to 1.25 EUR are expected. This corresponds to a dividend yield of 2.48 %.

In which sector is Recordati Industria Chimica e Farmaceutica SpA located?

Recordati Industria Chimica e Farmaceutica SpA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Recordati Industria Chimica e Farmaceutica SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Recordati Industria Chimica e Farmaceutica SpA from 11/20/2024 amounting to 0.6 EUR, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Recordati Industria Chimica e Farmaceutica SpA pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Recordati Industria Chimica e Farmaceutica SpA in the year 2023?

In the year 2023, Recordati Industria Chimica e Farmaceutica SpA distributed 1.12 EUR as dividends.

In which currency does Recordati Industria Chimica e Farmaceutica SpA pay out the dividend?

The dividends of Recordati Industria Chimica e Farmaceutica SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Recordati Industria Chimica e Farmaceutica SpA

Our stock analysis for Recordati Industria Chimica e Farmaceutica SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recordati Industria Chimica e Farmaceutica SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.